Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Times Interest Earned (2016 - 2024)

Historic Times Interest Earned for Fortress Biotech (FBIO) over the last 9 years, with Q4 2024 value amounting to -$8.83.

  • Fortress Biotech's Times Interest Earned rose 9549.92% to -$8.83 in Q4 2024 from the same period last year, while for Sep 2025 it was -$33.12, marking a year-over-year increase of 9063.07%. This contributed to the annual value of -$39.42 for FY2024, which is 9169.16% up from last year.
  • Latest data reveals that Fortress Biotech reported Times Interest Earned of -$8.83 as of Q4 2024, which was up 9549.92% from -$277.88 recorded in Q2 2024.
  • Over the past 5 years, Fortress Biotech's Times Interest Earned peaked at -$8.83 during Q4 2024, and registered a low of -$501.05 during Q2 2023.
  • Moreover, its 3-year median value for Times Interest Earned was -$196.14 (2023), whereas its average is -$230.28.
  • Within the past 5 years, the most significant YoY rise in Fortress Biotech's Times Interest Earned was 9549.92% (2024), while the steepest drop was 4454.05% (2024).
  • Over the past 3 years, Fortress Biotech's Times Interest Earned (Quarter) stood at -$124.81 in 2021, then plummeted by 57.15% to -$196.14 in 2023, then surged by 95.5% to -$8.83 in 2024.
  • Its Times Interest Earned stands at -$8.83 for Q4 2024, versus -$277.88 for Q2 2024 and -$365.66 for Q1 2024.